Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)	Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adenocarcinoma, appendix adenocarcinoma, carcinoma, carcinoma of esophagus, colorectal adenocarcinoma, cystic, mucinous, and serous neoplasm, digestive system disorder, digestive system neoplasm, disease, epithelial neoplasm, esophageal disorder, gastric neoplasm, mucinous adenocarcinoma, neoplasm, small intestine adenocarcinoma, stomach disorder	Recruiting	Phase 2	2026-08-31		NCT07795749

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of California, Irvine	157

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Chao Family Comprehensive Cancer Center, University of California, Irvine	Orange	United States	24